.png){kind=icon}
返回
Test data compression using Lingering Component Reduction technique for system-on-a-chip applications
.png){kind=icon}
PRE
AI
DOI：10.1016/j.compeleceng.2017.09.002.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
As technology, processes scale up, and design complexities grow, system-on-chip integration continues to rise rapidly. According to these trends, increasing test data volume is one of the largest challenges in the testing industry. In this work, we present a new test data compression method based on a stored set called Lingering Component Reduction (LCR) Code. The test set contains a large number of don't- care that can be exploited to improve the experimental data compression. In this method, a reference pattern is organized, and an adaptability of input pattern with reference pattern is reduced. The Lingering Component estimation based on test pattern contains more don't-care conditions that can be actively reduced to improve the test data compression on the Intellectual Property cores. The simulation results show the performance of experimental data compression ratio and testing time parameters. From the analysis of simulation results, it is proved that the proposed LCR code enhances a compression ratio and reduce the test time follows the International Symposium on Circuits and Systems'89. The comparative results of several benchmark circuits in maximum cases and compared the outputs of the many previous works without a substantial load on the hardware. (C) 2018 Elsevier Ltd. All rights reserved.
Keyword:
Lingering Component Reduction
Standard testing
A reference pattern Don't-care conditions
Intellectual property cores
International Symposium on Circuits and Systems'89
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
C
IF:
4.9
论文数:
6.7K
被引数:
1.3W
机构
引用论文
.png){kind=icon}
分享收藏SINGLE CENTER RETROSPECTIVE COMPARISON OF BIVALIRUDIN AND HEPARIN FOR THERAPEUTIC ANTICOAGULATION IN PEDIATRIC PATIENTS单中心回顾性比较：比伐卢定与肝素在儿科患者治疗性抗凝中的应用
PREAI
分享收藏The Impact of Implementing Clinic-Administered Vaccines in an Inflammatory Bowel Disease Outpatient Clinic在炎症性肠病门诊实施由诊所提供疫苗接种的影响
PREAI
分享收藏FACTOR XIII TESTING-WHAT IS AVAILABLE? WHAT ARE BEST PRACTICES FOR TESTING? EFFECT OF CONCENTRATES ON LAB TESTS? ANTIGEN VERSUS ACTIVITY TESTING? ANY REMAINING ROLE FOR CLOT SOLUBILITY?因子XIII检测——有哪些可用的方法？检测的最佳实践是什么？浓缩剂对实验室检测的影响？抗原检测与活性检测？凝血溶解检测是否仍有作用？
PREAI
分享收藏Evaluating the Effectiveness of Subcutaneous Ustekinumab Induction in Inflammatory Bowel Disease: Insights From Real-World Evidence评估皮下注射Ustekinumab诱导治疗在炎症性肠病中的有效性：来自真实世界证据的见解
PREAI
分享收藏Diabetes, Cardiorenal, and Metabolic Multispecialty Practice Recommendations and Early Intensive Management of Cardio-Renal-Metabolic Disease糖尿病、心肾和代谢多专科实践指南及心-肾-代谢疾病的早期强化管理
PREAI
分享收藏
查看更多内容